Sign in

CIK 0001370053

  • Non-accelerated filer
  • Smaller reporting company

ANAPTYSBIO, INC

Sign in to watch
Ticker
ANAB
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Jun 30
Incorporated
DE
Entity type
Operating
EIN
203828755
Phone
+1 858-362-6295
Business address
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA, 92121
Former names
ANAPTYSBIO INC, ANAPTYS BIOSCIENCES INC
  1. 4 Derivatives Options or other derivatives
  2. 4 Open-market sale President, CEO sold 36,645 shares at an average $35.57 ($1,303,559)
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 4 Grant or award Chief Medical Officer acquired 964 shares (grant or award)
  6. 4 Grant or award President, CEO acquired 964 shares (grant or award)
  7. 4 Grant or award COO, General Counsel acquired 523 shares (grant or award)
  8. 4 Grant or award Chief Financial Officer acquired 964 shares (grant or award)
  9. 4 Open-market sale President, CEO sold 20,361 shares at $35.00 ($712,635)
  10. 4 Open-market sale COO, General Counsel sold 5,000 shares at $35.00 ($175,000)
  11. 4 Open-market sale President, CEO sold 36,646 shares at an average $32.31 ($1,184,106)
  12. 4 Open-market sale President, CEO sold 15,993 shares at $30.00 ($479,790)
  13. 4 Exercise or conversion President, CEO acquired 10,000 shares (option exercise)
  14. 4 Exercise or conversion President, CEO acquired 10,000 shares (option exercise)
  15. 4 Open-market buy Director bought 221,500 shares at an average $23.24 ($5,147,444)
  16. 4 Open-market buy Director bought 147,300 shares at an average $23.63 ($3,480,233)
  17. 3 Insider Initial Statement of Ownership
  18. 4 Open-market buy 10% owner bought 3,308,800 shares at an average $18.93 ($62,622,736)
  19. 4 Open-market buy 10% owner bought 29,500 shares at $25.48 ($751,657)
  20. 4 Derivatives Options or other derivatives

Page 9 of 15 · 298 filings